ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR
- 专利权人:
- ABBVIE DEUTSCHLAND GMBH & CO. KG
- 发明人:
- HAUPT, ANDREAS
- 申请号：
- SG11201503144V
- 公开号：
- SG11201503144VA
- 申请日:
- 2013.10.21
- 申请国别(地区):
- SG
- 年份:
- 2015
- 代理人:
- 摘要：
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ACYLAMINOCYCLOALKYL COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF DOPAMINE D3 RECEPTOR
- HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR
- HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR
- תרכובות אצילאמינוציקלואלקיל המתאימות לטיפול בהפרעות המגיבות לאיפנון של קולטן דופאמין d3
- Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
